Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.23.3
STOCKHOLDERS' EQUITY (Details)
 3 Months Ended 9 Months Ended
Sep. 08, 2023
USD ($)
D
tranche
$ / shares
shares
Oct. 25, 2022
USD ($)
$ / shares
shares
Oct. 20, 2022
USD ($)
Jun. 27, 2022
Jun. 24, 2022
Aug. 11, 2020
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Mar. 31, 2023
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
$ / shares
STOCKHOLDERS' EQUITY                    
Warrants issued to purchase shares             28,668,953   28,668,953  
Number of warrants exercised             177,877   177,877  
Common stock par value | $ / shares             $ 0.00001   $ 0.00001 $ 0.00001
Proceeds from exercise of warrants | $             $ 348,638   $ 348,638  
Reverse stock split ratio       0.10            
Sales Agent | Equity Distribution Agreement                    
STOCKHOLDERS' EQUITY                    
Aggregate value of shares issued | $           $ 14,500,000        
Common stock par value | $ / shares           $ 0.00001        
Commission paid on sale of shares (in percentage)           3.00%        
Common Stock                    
STOCKHOLDERS' EQUITY                    
Conversion of pre-funded warrants into common shares (in shares)               355,235    
Minimum                    
STOCKHOLDERS' EQUITY                    
Reverse stock split ratio         0.10          
Maximum                    
STOCKHOLDERS' EQUITY                    
Reverse stock split ratio         0.20          
October 2022 Public Offering and Private Placement                    
STOCKHOLDERS' EQUITY                    
Warrants issued to purchase shares   3,275,153                
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.085                
Class of warrant or rights from which warrants or rights exercisable. | $ / shares   $ 0.00001                
Gross proceeds | $   $ 10,700,000                
Estimated offering expenses | $   $ 9,600,000                
Gross proceeds from stockholders' equity | $     $ 10,700,000              
October 2022 Public Offering and Private Placement | Common Stock                    
STOCKHOLDERS' EQUITY                    
Warrants issued to purchase shares   1,875,945                
Exercise price of warrants (in dollars per share) | $ / shares   $ 1.96                
Common Stock | October 2022 Public Offering and Private Placement                    
STOCKHOLDERS' EQUITY                    
Conversion of pre-funded warrants into common shares (in shares)                 355,235  
Gross proceeds from stockholders' equity | $     4,000,000.0              
Common warrants | October 2022 Public Offering and Private Placement                    
STOCKHOLDERS' EQUITY                    
Gross proceeds from stockholders' equity | $     4,400,000              
Prefunded Warrant | October 2022 Public Offering and Private Placement                    
STOCKHOLDERS' EQUITY                    
Warrants issued to purchase shares   1,875,945                
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.08499                
pre-funded warrants                 355,235  
Number of warrants exercised             0      
Gross proceeds from stockholders' equity | $     $ 2,300,000              
September 2023 Private Placement                    
STOCKHOLDERS' EQUITY                    
Gross proceeds | $ $ 24,500,000                  
Net proceeds | $ $ 22,100,000                  
Number of tranches | tranche 2                  
September 2023 Private Placement | Series E Warrants                    
STOCKHOLDERS' EQUITY                    
Share price | $ / shares $ 20,000                  
September 2023 Private Placement | Series E-1 preferred stock                    
STOCKHOLDERS' EQUITY                    
Shares issued 1,225                  
Conversion price per share | $ / shares $ 1.82                  
Convertible preferred shares issued 13,461,538                  
September 2023 Private Placement | Series E-3 preferred stock                    
STOCKHOLDERS' EQUITY                    
Conversion price per share | $ / shares $ 3.185                  
Convertible preferred shares issued 13,846,154                  
September 2023 Private Placement | Series E-4 preferred stock                    
STOCKHOLDERS' EQUITY                    
Conversion price per share | $ / shares $ 4.7775                  
Convertible preferred shares issued 7,179,487                  
September 2023 Private Placement | 2023 Tranche A Preferred Warrants                    
STOCKHOLDERS' EQUITY                    
Proceeds from exercise of warrants | $ $ 44,100,000                  
September 2023 Private Placement | 2023 Tranche A Preferred Warrants | Series E-3 preferred stock                    
STOCKHOLDERS' EQUITY                    
Warrants issued to purchase shares 2,205                  
Number of days | D 10                  
September 2023 Private Placement | 2023 Tranche B Preferred Warrants | Series E-4 preferred stock                    
STOCKHOLDERS' EQUITY                    
Warrants issued to purchase shares 1,715                  
Number of days | D 10                  
Proceeds from exercise of warrants | $ $ 34,300,000